Clarity Pharmaceuticals Ltd
Status: Publicly traded
Direct answer
Clarity Pharmaceuticals Ltd is publicly traded on ASX under the ticker CU6.AX.
Clarity Pharmaceuticals Ltd. is a clinical-stage company focused on developing innovative radiopharmaceutical products that serve as both diagnostic imaging tools and therapeutic agents for cancer treatment in both children and adults. Its primary offering is SARTATE, a targeted theranostic radiopharmaceutical specifically engineered for the diagnosis, staging, and treatment of cancers characterized by somatostatin...
Can you invest in Clarity Pharmaceuticals Ltd?
Yes. Clarity Pharmaceuticals Ltd is publicly traded on ASX under the ticker CU6.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Clarity Pharmaceuticals Ltd
Detailed equity research is provided by MarketSnap.